Dendreon shares Left for Dead?
There are the crazy price targets such as $18 by Maxim Group set in September and more reasonable $7 from Baird back in August. Going with BofA would represent a 44% increase to get back to $6 from today's price. Take a look at the crack price tp of $18, a 300%+ increase in the next 12 months...really?
|Ticker||Current Price||Target Price||% Increase|
Dendreon reports Q3 earnings at the end of the month on October 30th. Expect the stock to tread water until we hear something at that time. What could work for playing the conference call is a covered call on DNDN to protect your neck.
MASTERY Bottom line:
Provenge has a bunch of competition and when it costs $100K per patient, its not going to everyone who could really benefit from it.
Medivation (MDVN) and Astellas Pharma (ALPMY.PK) are getting ready to take on Provenge with their prostate cancer fighting drug Xtandi. There is room in the prostate cancer arena, these drugs are used at different stages of treating prostate cancer. Johnson & Johnson's (JNJ) Zytiga is also competing in this space as is Jevtana from Sanofi. The prostate cancer treatment field is getting crowded, its why DNDN has tanked to $4.
However Dendreon isn't dead yet. The stock can go lower but at $4 its worth a few bucks to go long.
Best of the Blogs
Scanning and identifying the best blog entries every hour
- Breaking The Correlation Curse | ZeroHedge
- It Is Always About Money (Video) | ZeroHedge
- Irexit: Ireland May Have to Consider Leaving the EU | Financial Sense
- Giuliani Reportedly Out Of Running For Secretary Of State | ZeroHedge
- Extending Lifespans and Healthspans May Be Closer Than You Think | Financial Sense
- Are Fiscal Stimulus Expectations Too High? | Financial Sense
- Restoration Hardware Implodes After More Terrible Guidance, Blames Election | ZeroHedge
The most relevant financial news and articles from the Internets
- TONY ROBBINS: How to make a good first impression | Business Insider
- Take an inside look at the New York offices of Facebook, LinkedIn, and 7... | Business Insider
- Never-before-seen photos show candid moments with some of the biggest rock stars... | Business Insider
- Why some Trump supporters are boycotting the new 'Star Wars'... | Business Insider
- The 10 things in advertising you need to know today | Business Insider
- The easiest way to figure out who a mystery iPhone belongs to (AAPL) | Business Insider
- 'DISCIPLINED MEDAL-WINNING... | Business Insider